Stocktoria

Tanke Biosciences Corp TNBI

OTC · stock · Grain Mill Products · website · IPO 2011-02-10

Tanke Biosciences Corp statistics & valuation

Market cap$380,000
P / S0.0×
P / B0.0×
Net margin-0.7%
Return on equity-1.3%
FCF margin-7.1%
Net cash$4.1M
Net debt / EBITDA-0.8×
Enterprise value USD-$3.7M
Return on capital27%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
13.60% -13.20% -0.70% 201020112012
Gross margin (%)
36.80% 36.80% 34.80% 201020112012
Operating margin (%)
21.80% 7.30% 15.90% 201020112012
Return on equity (%)
26.50% -19.80% -1.30% 201020112012
Shares outstanding
10.8M 13.3M 13.3M 201020112012
Net debt ($)
-$1.8M -$6.3M -$4.1M 201020112012
Share buybacks ($)
201020112012
Return on assets (%)
20.60% -12.60% -0.70% 201020112012
Free cash flow margin (%)
21.40% 11.90% -7.10% 201020112012
Debt / equity (×)
0.04× 0.09× 0.13× 201020112012
EPS ($)
$0.34 -$0.24 201020112012

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2012FY2011FY2010
Gross margin34.8%36.8%36.8%
Operating margin15.9%7.3%21.8%
Net margin-0.7%-13.2%13.6%
FCF margin-7.1%11.9%21.4%
Return on assets-0.7%-12.6%20.6%
Return on equity-1.3%-19.8%26.5%
Debt / equity0.13×0.09×0.04×
Current ratio1.855.333.19

Computed from company filings · US · as of 2012-12-31. Facts plus Stocktoria's own computed scores — not investment advice.